Research funding after specialist medical training
The Advanced Clinician Scientist Program iIMMUNE_ACS supports outstanding, research-oriented physicians after completing their specialist training. It is an extension of the specialist-accompanying Clinician Scientist Programs at the IZKF (CSPI and II) and the DZI (NOTICE). The funded Advanced Clinician Scientists (ACS) are given the opportunity to carry out a research project in the field of immune medicine alongside their clinical work and to prepare themselves for a clinical-scientific leadership role through an advanced, interdisciplinary training program. iIMMUNE_ACS guarantees the funded specialists a protected research time of 50%, as well as additional funds for research. An individually appointed team of mentors supports the ACS Fellows in achieving their defined goals. Our flyer
Connection of iIMMUNE_ACS to FAU research centers
iIMMUNE_ACS enables ACS Fellows to use the existing excellent research infrastructure at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU). This enables ACS Fellows to expand their knowledge in areas relevant to their research and to learn and apply new techniques. Possible collaborations include the following research centers and research networks at FAU:
The Erlangen site and the DZI (Deutsche Zentrum Immuntherapie)
At Erlangen University Hospital and FAU Erlangen-Nuremberg, the field of immunotherapy has been continuously expanded in recent years and strengthened through targeted appointments. The German Center for Immunotherapy (DZI), the Center for Immunotherapy, Biophysics & Digital Medicine (CITABLE) and the Max Planck Center for Physics and Medicine (MPZPM) provide a unique research environment for translational research in the field of immunotherapy. CAR-T cell therapy was used to successfully treat Lupus erythematosus and Myositis for the first time worldwide at the University Hospital Erlangen.
The DZI, a unique institution in Germany, pools the expertise of clinics and research institutes in Erlangen. The aim of the facility is to combine immunomedicine with the latest scientific methods of biophysics and artificial intelligence with digital health technology. Thanks to the interdisciplinary collaboration of various disciplines, immunotherapies for patients with chronic inflammatory diseases, autoimmune diseases and cancer can be applied and further developed here.
Contact and further information
Coordination:Dr. Jasmin Raufer | Program director:Prof. Beate Winner | Substitute Program director:Prof. Maximilian Waldner |
Other ACS locations funded by the Federal Ministry of Research, Technology and Space (BMFTR)
| Dresden | CAMINO – Career Advancement in MultIdimeNsional tumOr targeting | |
| Frankfurt | INITIALISE – Innovations in Infection Medicine | |
| Freiburg | IMMediate – Immune-Mediated Diseases | |
| Essen | UMEA² – Promoting Excellence in Translational Medicine | |
| Hamburg | iSTAR – integrative Advanced Clinician Scientists Targeting Inflammatory and Infectious Disease | „Fast-track application" for external applications: iSTAR(at)uke.de |
| Bonn | ACCENT – Advanced Clinician Scientist Program Bonn | |
| Würzburg | INTERACT – Interfaces in Translational Research |
